Abstract
To validate the protective efficacy against schistosomiasis by immunization with cells from juvenile Schistosoma japonicum in a murine model and to analyze possible factors related to protection, in this study, two independent repeated vaccination trials were performed. After three subcutaneous vaccinations, in trial one, in the absence of adjuvant, primary juvenile worm cells (pJCs) from S. japonicum induced remarkable average reductions in worm burden (54.3%), liver eggs per gram (LEPG) load (59.8%) as well as egg granulomas size (66.5%) compared to PBS control group (P<0.01), which were significantly higher than those elicited by fractions of juvenile worm cells (JCFs) or fractions of juvenile worms (JWFs) (P<0.05). Non-cell components of worms (WNCs) showed no significant protection. In trial two, compared to PBS control group, significant protective effect was also observed for cultured juvenile worm cells (cJCs) from S. japonicum with 58.4% worm reduction and 68.1% LEPG reduction (P<0.01). However, cultured adult worms cells (cACs) showed significantly higher worm burden (P<0.05) and egg burden (P<0.01) when compared to cJCs. Immunological analysis of trial two revealed that cJCs engendered a Th1-biased mixed Th1/Th2 type of immune response while cACs elicited a Th2-type response. Our data indicated that immunization with both primary and cultured cells from S. japonicum juvenile worms provided high immunoprotection, for which the physical character of immunogens, stage-specific parasite and the type of immune response induced might be responsible, suggesting that vaccination with whole cells from S. japonicum larvae is a promising approach to produce protective immunity against schistosomiasis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bergquist N R, Colley D G. Schistosomiasis vaccines: research to development. Parasitol Today, 1998, 14(3): 99–104, 17040715, 10.1016/S0169-4758(97)01207-6, 1:STN:280:DC%2BD28ngvFSgsw%3D%3D
Hewitson J P, Hamblin P A, Mountford A P. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol, 2005, 27(7–8): 271–280, 16138848, 10.1111/j.1365-3024.2005.00764.x, 1:CAS:528:DC%2BD2MXhtFars7vJ
Coulson P S. The radiation-attenuated vaccine against schistosomes in animal models: Paradigm for human vaccine? Adv Parasitol, 1997, 39, 271–336, 9241818, 1:STN:280:DyaK2szosFyjtg%3D%3D, 10.1016/S0065-308X(08)60048-2
Ford M J, Bickle Q D, Taylor M G. Immunization of rats against Schistosoma mansoni using irradiated cercariae, lung schistosomula and liver-stage worms. Parasitology 1984, 89(Pt 2): 327–344, 6504562
James S L, Pearce E J. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis. J Immunol, 1988, 140(8): 2753–2759, 3128608, 1:CAS:528:DyaL1cXitVartr0%3D
Hsü S Y, Hsü H F, Svestka K W, et al. Vaccination against schistosomiasis in mice with killed schistosomula without adjuvant. Proc Soc Exp Biol Med, 1986, 181(3): 454–458, 3080758
Afifi M A, El-Wakil H S, Abdel-Ghaffar M M, et al. Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants. J Egypt Soc Parasitol, 2006, 36(1): 351–362, 16605124
McManus D P, Bartley B P. A vaccine against Asian schistosomiasis. Parasitol Int, 2004, 53(2): 163–173, 15081948, 10.1016/j.parint.2004.01.006, 1:CAS:528:DC%2BD2cXjtVCnsLo%3D
Bergquist R, Al-Sherbiny M, Barakat R, et al. Blueprint for schistosomiasis vaccine development. Acta Trop, 2002, 82(2): 183–192, 12020891, 10.1016/S0001-706X(02)00048-7
McManus D P. The search for a vaccine against schistosomiasis — a difficult path but an achievable goal. Immunol Rev, 1999, 171: 149–161, 10582169, 10.1111/j.1600-065X.1999.tb01346.x, 1:CAS:528:DyaK1MXnvVSiu7o%3D
Zhang Y, Taylor M G, Johansen M V, et al. Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection. Vaccine, 2001, 20(5–6): 724–730, 11738735, 10.1016/S0264-410X(01)00420-0, 1:CAS:528:DC%2BD3MXptVSnsLg%3D
Wei Y Q, Wang Q R, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med, 2000, 6(10): 1160–1166, 11017149, 10.1038/80506, 1:STN:280:DC%2BD3M%2Fis1Wquw%3D%3D
Vermorken J B, Claessen A M, van Tinteren H, et al. Active-specific immunotherapy for stage II and stage III human colon cancer: A randomized trial. Lancet, 1999, 353(9150): 345–350, 9950438, 10.1016/S0140-6736(98)07186-4, 1:STN:280:DyaK1M7jtl2gtQ%3D%3D
Sinkovics J G, Horvath J C. Vaccination against human cancers. Int J Oncol, 2000, 16(1): 81–96., 10601552, 1:CAS:528:DC%2BD3cXjvFWguw%3D%3D
Canthaboo C, Williams L, Xing D K L, et al. Investigation of cellular and humoral immune response to whole cell and acellular pertussis vaccine. Vaccine, 2001, 19(6): 637–643, 10.1016/S0264-410X(00)00253-X
Pace J L, Rossi H A, Esposito V M, et al. Inactivated whole-cell bacterial vaccines: Current status and novel strategies. Vaccine, 1998, 16(16): 1563–1574, 9711805, 10.1016/S0264-410X(98)00046-2, 1:STN:280:DyaK1cznslKrtg%3D%3D
Armijos R X, Weigel M M, Calvopina M, et al. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis. Vaccine, 2004, 22(9–10): 1320–1326, 15003662, 10.1016/j.vaccine.2003.06.002, 1:CAS:528:DC%2BD2cXhslCjs7o%3D
Zhang Z Y, Li L R. Researches on the cytological prophylaxis and treatment of parasitosis. J Tianjin Agric Coll (in Chinese), 2001, 8(1): 5–8
Liu W, Zeng T B, Zeng Q R, et al. Biological identification on sub-cultivation cells of Schistosoma japonicum adult worms in vitro. Chin J Parasitol Parasit Dis (in Chinese), 2006, 24(5): 375–378
Zeng Q R, Lin X C, Gong Y F, et al. Study on the protective immunity in mouse induced by a new type of vaccine, live cells of Schistosoma japonicum schistosomulum. Chin J Mod Medic (in Chinese), 2004, 14(14): 84–97
Wright M D, Davern K M, Mitchell G F. The functional and immunological significance of some schistosome surface molecules. Parasitol Today, 1991, 7(2): 56–58, 15463423, 10.1016/0169-4758(91)90191-P, 1:CAS:528:DyaK3MXmt12lu7k%3D
Smithers S R, Hackett F, Orrier Ali P, et al. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes. Parasite Immunol, 1989, 11(4): 301–318, 2476710, 10.1111/j.1365-3024.1989.tb00669.x, 1:STN:280:DyaL1MzosFKktg%3D%3D
Capron A, Dessaint J P. Molecular basis of host-parasite relationship: Towards the definition of protective antigens. Immunol Rev, 1989, 112: 27–48, 2691390, 10.1111/j.1600-065X.1989.tb00551.x, 1:CAS:528:DyaK3cXhsFKhsbs%3D
Willadaen P, Eiseman C H, Tellam R L. ’Concealed’ antigens: Expanding the range of immunological targets. Parasitol Today, 1993, 9(4): 132–135, 10.1016/0169-4758(93)90177-H
Braschi S, Wilson R A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics, 2006, 5(2): 347–356, 16269422, 10.1074/mcp.M500287-MCP200, 1:CAS:528:DC%2BD28XitVagsbw%3D
Woolhouse M E. A theoretical framework for the immunoepidemiology of blocking antibodies to helminth infection. Parasite Immunol, 1994, 16(8): 415–424, 7808762, 10.1111/j.1365-3024.1994.tb00369.x, 1:STN:280:DyaK2M7gslKmsQ%3D%3D
Diwan M, Elamanchili P, Cao M, et al. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Curr Drug Deliv, 2004, 1(4): 405–412, 16305402, 10.2174/1567201043334597, 1:CAS:528:DC%2BD2cXnsFWks7g%3D
Telino E, De Luca P M, Matos D C, et al. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin Exp Immunol, 2006, 143(2): 338–344, 16412059, 10.1111/j.1365-2249.2006.02995.x, 1:CAS:528:DC%2BD28Xit1alsr0%3D
Pearce E J, James S L, Dalton J, et al. Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. J Immunol, 1986, 137(11): 3593–3600., 2431037, 1:CAS:528:DyaL2sXjtFSktw%3D%3D
Coulson P S, Mountford A P. Fate of attenuated schistosomula administered to mice by different routes, relative to the immunity induced against Schistosoma mansoni. Parasitology, 1989, 99(Pt 1): 39–45, 2508038, 10.1017/S003118200006100X
Mountford A P, Harrop R, Wilson R A. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infect Immunol, 1995, 63(5): 1980–1986, 1:CAS:528:DyaK2MXlt1amtL4%3D
Mountford A P, Harrop R. Vaccination against Schistosomiasis: The case for Lung-stage Antigens. Parasitol Today, 1998, 14(3): 109–114, 17040717, 10.1016/S0169-4758(97)01169-1, 1:STN:280:DC%2BD28ngvFSgsQ%3D%3D
Medley G, Anderson R M. Density-dependent fecundity in Schistosoma mansoni infections in man. Trans R Sot Trap Med Hyg, 1985, 79: 532–534, 10.1016/0035-9203(85)90087-2, 1:STN:280:DyaL28%2FpvVWhsA%3D%3D
Wilson R A, Coulson P S, Betts C, et al. Impaired immunity and altered pulmonary response in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology, 1996, 87(2): 275–282, 8698391, 10.1046/j.1365-2567.1996.465550.x, 1:CAS:528:DyaK28Xht1Gku74%3D
Jankovic D, Wynn T A, Kullberg M C, et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B celland IFN-gamma-dependent effector mechanisms. J Immunol, 1999, 162(1): 345–351, 9886405, 1:CAS:528:DyaK1MXjt1Olsg%3D%3D
Wynn T A, Hoffmann K F. Defining a schistosomiasis vaccination strategy — is it really Th1 versus Th2? Parasitol Today, 2000, 16(11): 497–501, 11063861, 10.1016/S0169-4758(00)01788-9, 1:CAS:528:DC%2BD3cXosFKgsrs%3D
Finkelman F D, Holmes J, Katona I M, et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol, 1990, 8: 303–333, 1693082, 10.1146/annurev.iy.08.040190.001511, 1:CAS:528:DyaK3cXkvFGksLs%3D
Seder R A, Paul W E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol, 1994, 12(Pt 6): 635–673, 7912089, 10.1146/annurev.iy.12.040194.003223, 1:CAS:528:DyaK2cXivFKisr4%3D
Author information
Authors and Affiliations
Corresponding author
Additional information
The first two authors should be regarded as joint first authors
Supported by the National Natural Science Foundation of China (Grant No. 30570952)
Rights and permissions
About this article
Cite this article
Zeng, T., Cai, L., Zeng, Q. et al. Immunization of mice with cells from juvenile worms of Schistosoma japonicum provides immunoprotection against schistosomiasis. SCI CHINA SER C 50, 822–830 (2007). https://doi.org/10.1007/s11427-007-0100-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-007-0100-7